Intercept Pharma (NASDAQ: ICPT) announced the achievement of two important regulatory milestones for obeticholic acid (OCA) in primary biliary cirrhosis ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE